Protocolo de indicación de la anticoagulación

Kearon, 2016, Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report, Chest., 149, 315, 10.1016/j.chest.2015.11.026 Ruff, 2014, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, Lancet., 383, 955, 10.1016/S0140-6736(13)62343-0 Siegal, 2014, How I treat target-specific oral anticoagulant-associated bleeding, Blood, 123, 1152, 10.1182/blood-2013-09-529784 Pollack, 2015, Idarucizumab for dabigatran reversal, N Engl J Med., 373, 511, 10.1056/NEJMoa1502000 Cuker, 2015, Monitoring and reversal of direct oral anticoagulants, Hematology Am Soc Hematol Educ Program., 2015, 117, 10.1182/asheducation-2015.1.117 Douketis JD1, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141Suppl2:e326S-50S.